bupropion 150 mg xl
bupropion 150 mg xl: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Lead developer: CG Oncology, Inc. (CGON)
Development Pipeline (1)
| Company | Phase |
|---|---|
| CG Oncology, Inc. (CGON) | Phase 2 |
Clinical Trials (1)
Phase II Double Blind Dose Finding Trial of Bupropion Versus Placebo for Sexual Desire in Women With Breast or Gynecologic Cancer
Frequently asked questions
Who is developing bupropion 150 mg xl?
bupropion 150 mg xl is being developed by CG Oncology, Inc..
How many clinical trials involve bupropion 150 mg xl?
BioSniper tracks 1 clinical trial involving bupropion 150 mg xl.
Analyze CG Oncology, Inc. & bupropion 150 mg xl with AI
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
- 200 free AI credits / month to run live multi-agent analysis
- Watchlist, catalyst alerts & the biotech event calendar
- Full pipeline, financials & FDA data on every company